A comprehensive view of Weight Management Products. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Transformation & Innovation Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Novo Nordisk slashes Ozempic diabetes drug cost from 1,313.35 Danish krone to 873.35 Danish krone per package
Published: May 10, 2024 by M-Brain Nordic News
Citi rates Novo Nordisk at buy, expecting its sales to grow by 27% in 2024, as price of GLP-1 drugs fall and clinical data support their use; Novo has 12 million patients on GLP-1 drugs, while addressable population for treatment approaches 1 billion
Published: May 08, 2024 by Proactive Investors
Amgen halts development of weight loss pill, shifts focus to its injectable drug MariTide and other obesity products; prepares for stage two trial of MariTide as diabetes treatment
Published: May 03, 2024 by Baystreet US News Alerts
Novo Nordisk's Q1 earnings beat expectations, with a 22% YoY increase in net sales to US$9.4B and a 28% YoY rise in net profit to US$3.65B; results driven by a surge in demand for its weight loss and diabetes drugs Ozempic and Wegovy
Published: May 02, 2024 by Forbes
Eli Lilly's weight loss drug Mounjaro drives record Q1 earnings with worldwide revenue of US$1.81B; the results push the company to increase its full-year 2024 revenue guidance by US$2.0B
Published: April 30, 2024 by Proactive Investors

Ask us about our Transformation & Innovation market view

Trending Chart

Interactive chart with headline count